patent/PA-8606001-A1

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PA-8606001-A1

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
filingDate	2004-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79cec613c3c94c3d4376704736b26415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21919fca0cb6b6112cc5407051b50768 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f31656c8a45814bf5646196f9322d9dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5945f6ec2200deb3ec52899bc97805b0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_534683b566711b79535c693927381403
publicationDate	2005-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	PA-8606001-A1
titleOfInvention	SAQUINAVIR MESILATO, ORAL DOSAGE FORM
abstract	A ORAL SOLAR UNITMAR PHARMACEUTICAL DOSAGE METHOD OF SAQUINAVIR MESILATO CONTAINING THE SAQUINAVIR MICRONIZED MESILATE IS PROVIDED IN A QUANTITY INCLUDED BETWEEN 250 MG AND 800 MG, CALCULATED AS A FREE BASE, AND A UNDERLY AGRICULTURAL UNDERTAKABLE AGENT. A UNIT SOLID SOLID DOSAGE FORM IS PROVIDED FOR SAQUINAVIR MESILATO CONTAINING FROM 60% TO 80% OF SAQUINAVIR MICRONIZED MESILATE BASED ON MESILATE SALT, 4% TO 8% WATER SOLUBLE BINDER, A DISINTEGRANT AND A EXCIPIENT, IN WHICH EVERY PERCENTAGE REFERS TO THE NUCLEUS WEIGHT.
priorityDate	2003-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441243 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503904

Total number of triples: 30.